Wet age-related macular degeneration.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2005-12-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.ADDR.2005.09.003PMID 16309781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basal linear deposit in the human macula

  2005cited by this paper
• Complement Factor H Polymorphism and Age-Related Macular Degeneration

  2005cited by this paper
• Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

  2005cited by this paper
• Senile macular degeneration: The involvement of immunocompetent cells

  2005cited by this paper
• Complement Factor H Polymorphism in Age-Related Macular Degeneration

  2005cited by this paper
• Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis

  2005cited by this paper
• A prospective multicenter clinical trial to evaluate the safety and effectiveness of the implantable miniature telescope.

  2004cited by this paper
• Optical coherence tomography—a review of the principles and contemporary uses in retinal investigation

  2004cited by this paper
• Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.

  2004cited by this paper
• Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.

  2004cited by this paper
• Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center.

  2004cited by this paper
• Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results.

  2003cited by this paper
• A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.

  2003cited by this paper
• Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes.

  2003cited by this paper
• Lutein and zeaxanthin status and risk of age-related macular degeneration.

  2003cited by this paper
• Relation of statin use to the 5-year incidence and progression of age-related maculopathy.

  2003cited by this paper
• VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization

  2003cited by this paper
• Intravitreal triamcinolone acetonide for exudative age related macular degeneration

  2003cited by this paper
• Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

  2003cited by this paper
• Intraocular pressure after intravitreal injection of triamcinolone acetonide

  2003cited by this paper
• Age-related macular degeneration: a new viewpoint.

  2003cited by this paper
• The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study.

  2003cited by this paper
• The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study.

  2002cited by this paper
• Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

  2002cited by this paper
• GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES

  2002cited by this paper
• Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.

  2002cited by this paper
• Optimizing treatment of choroidal neovascularization feeder vessels associated with age-related macular degeneration.

  2002cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

  2001cited by this paper
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

  2001cited by this paper
• Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).

  2001cited by this paper
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

  2001cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

  2001cited by this paper
• Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials.

  2000cited by this paper
• INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE‐RELATED MACULAR DEGENERATION

  2000cited by this paper
• Submacular surgery: a millennium update.

  2000cited by this paper
• Complications associated with limited macular translocation.

  2000cited by this paper
• Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study.

  2000cited by this paper
• Simple and complex ABCR: genetic predisposition to retinal disease.

  2000cited by this paper
• Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey.

  1999cited by this paper
• Macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration: a prospective study.

  1999cited by this paper
• Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration.

  1999cited by this paper
• Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy.

  1999cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

  1999cited by this paper
• Genetic risk of age-related maculopathy. Population-based familial aggregation study.

  1998cited by this paper
• The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration

  1998cited by this paper
• Family history and age-related maculopathy: the Blue Mountains Eye Study.

  1998cited by this paper
• A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration. Comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients.

  1998cited by this paper
• The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration.

  1998cited by this paper
• Genetic association of apolipoprotein E with age-related macular degeneration.

  1998cited by this paper
• Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.

  1998cited by this paper
• Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group.

  1997cited by this paper
• Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.

  1997cited by this paper
• Indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization.

  1997cited by this paper
• The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study.

  1997cited by this paper
• Sun exposure and age-related macular degeneration. An Australian case-control study.

  1997cited by this paper
• Development of exudative age-related macular degeneration after cataract surgery

  1997cited by this paper
• Mutation of the Stargardt Disease Gene (ABCR) in Age-Related Macular Degeneration

  1997cited by this paper
• An intraocular telescopic lens for macular degeneration.

  1997cited by this paper
• Familial aggregation of age-related maculopathy.

  1997cited by this paper
• Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor.

  1996cited by this paper
• Optical coherence tomography of age-related macular degeneration and choroidal neovascularization.

  1996cited by this paper
• Smoking and age-related maculopathy. The Blue Mountains Eye Study.

  1996cited by this paper
• Radiation therapy for subretinal neovascularization.

  1996cited by this paper
• Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey.

  1995cited by this paper
• A twin study of age-related macular degeneration.

  1995cited by this paper
• Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage.

  1994cited by this paper
• Is genetic predisposition an important risk factor in age-related macular degeneration?

  1994cited by this paper
• Heredity and age-related macular degeneration. Observations in monozygotic twins.

  1994cited by this paper
• Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration.

  1994cited by this paper
• Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment.

  1993cited by this paper
• Laser treatment of choroidal neovascularization in patients with angioid streaks.

  1993cited by this paper
• Sunlight and age-related macular degeneration. The Beaver Dam Eye Study.

  1993cited by this paper
• The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking.

  1993cited by this paper
• Prevalence of age-related maculopathy. The Beaver Dam Eye Study.

  1992cited by this paper
• Clinicopathologic Correlation of Occult Choroidal Neovascularization in Age-Related Macular Degeneration

  1992cited by this paper
• The long-term effects of visible light on the eye.

  1992cited by this paper
• Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group.

  1991cited by this paper
• [A role of the retinal pigment epithelium in the involution of subretinal neovascularization].

  1990cited by this paper
• Growth rate of subretinal neovascularization in age-related macular degeneration.

  1989cited by this paper
• Vascular endothelial growth factor is a secreted angiogenic mitogen.

  1989cited by this paper
• Progressive ultrastructural damage and thickening of the basement membrane of the retinal pigment epithelium in spontaneously diabetic BB rats.

  1988cited by this paper
• Changes in the diabetic choroidal vasculature: scanning electron microscopy findings.

  1988cited by this paper
• The role of retinal pigment epithelium in the involution of subretinal neovascularization.

  1986cited by this paper
• Earliest symptoms caused by neovascular membranes in the macula.

  1986cited by this paper
• Pathologic Features of Senile Macular Degeneration

  1985cited by this paper
• Recurrent subretinal neovascularization.

  1985cited by this paper
• Prognosis of patients with bilateral macular drusen.

  1984cited by this paper
• Choroidal neovascularization can digest Bruch's membrane. A prior break is not essential.

  1984cited by this paper
• Subretinal neovascularization. Natural history of an experimental model.

  1982cited by this paper
• The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

  1980cited by this paper
• Ageing and degeneration in the macular region: a clinico-pathological study.

  1976cited by this paper
• Drusen and disciform macular detachment and degeneration.

  1972cited by this paper
• Pathogenesis of disciform detachment of the neuroepithelium.

  1967cited by this paper

• Changes in ApoE and TIMP-1 expression correlate with outer blood-retinal barrier disruption in an in vitro model of retinal aging.

  2026cites this paper
• DNA Nanoflower LYTACs Enable Efficient VEGF Degradation and Verteporfin Loading for Combined Therapy of Wet Age-Related Macular Degeneration.

  2026cites this paper
• An Interpretable Diagnosis of Retinal Diseases Using Vision Transformer and Grad-CAM

  2025cites this paper
• Neovascular age‐related macular degeneration on three nationwide survey and register data in Finland during 2000–2017

  2025cites this paper
• RNA Methylation Homeostasis in Ocular Diseases: All Eyes on Me.

  2025cites this paper
• Ophthalmic formulation of methotrexate: a strategy of using the self-assembled LacAC4A nanoparticles for non-invasive drug delivery to the ocular posterior segment

  2025cites this paper
• Local controlled release of stabilized monoclonal antibodies.

  2025cites this paper
• Revolutionizing age-related macular degeneration treatment: Advances and future directions in non-invasive retinal drug delivery systems.

  2025cites this paper
• Comparison of the Efficiency and Safety of Photodynamic Therapy Combined Intravitreal Bevacizumab and Intravitreal Triamcinolone Treatments in Age-Related Macular Degeneration

  2024cites this paper
• Photosensitizer formulations in photodynamic therapy of age-related macular degeneration.

  2024cites this paper
• Assessment of optical coherence tomography biomarkers in patients with non-neovascular age-related macular degeneration (AMD) converting to exudative AMD according to the status of the fellow eye

  2024cites this paper
• Advanced nanomedicines for the treatment of age-related macular degeneration.

  2024cites this paper
• Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems.

  2024cites this paper
• Evaluation of the Effect of Age-Related Macular Degeneration Type And Stage on the Risk of Parkinson’s Disease

  2024cites this paper
• Comparative Deep Learning Architectures to Detect Tiny Features in Ophthalmic Imaging

  2023cites this paper
• 51.2: Simulating the Visual Impairment Symptoms of Age‐related Macular Degeneration in Virtual Reality

  2023cites this paper
• OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy

  2023cites this paper
• Rethinking the potential and necessity of drug delivery systems in neovascular age-related macular degeneration therapy

  2023cites this paper
• Biomaterial Drug Delivery Systems for Prominent Ocular Diseases

  2023cites this paper
• Influence of carrier materials and coatings on retinal pigment epithelium cultivation and functions.

  2022cites this paper
• The retinal pigment epithelium

  2021cites this paper
• Long-term fundus fluorescence angiography and real-time diagnosis of retinal diseases in non-human primate-animal models

  2021cites this paper
• Aqueous Humor Levels of Vascular Endothelial Growth Factor and Stromal Cell-Derived Factor-1α in Age-Related Macular Degeneration

  2021cites this paper
• Computer-Aided Age-Related Macular Degeneration Diagnosis with the Fusion of Both Color Fundus and Fluorescein Angiography

  2020cites this paper
• Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy

  2020cites this paper
• Cytokine Profiles and the Effect of Intravitreal Aflibercept Treatment on Experimental Choroidal Neovascularization

  2020cites this paper
• Türkiye’de Yaşa Bağlı Maküla Dejenerasyonunda Endikasyon Dışı İlaç Kullanımı

  2020cites this paper
• Activation of JNK signaling promotes all-trans-retinal–induced photoreceptor apoptosis in mice

  2020influential citation
• Bio-inspired human in vitro outer retinal models: Bruch's membrane and its cellular interactions.

  2020cites this paper
• Preclinical Evaluation of UDCA-Containing Oral Formulation in Mice for the Treatment of Wet Age-Related Macular Degeneration

  2019cites this paper
• Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium-Role in Dead Cell Clearance and Inflammation

  2019cites this paper
• Evaluating the Effect of Intravitreal Ranibizumab on Retrobulbar Hemodynamics by Color Doppler Ultrasonography in Neovascular AMD.

  2019cites this paper
• A review on recent advancements in ophthalmology devices: Currently in market and under clinical trials

  2019cites this paper
• Vitamin D and Age-Related Macular Degeneration

  2018influential citation
• Photodynamic Therapy for Treatment of Subfoveal Choroidal Neovascularization in Exudative Age-Related Macular Degeneration

  2018cites this paper
• Rational design of liposomes for sustained release drug delivery of bevacizumab to treat ocular angiogenesis

  2018cites this paper
• Synthesis of magnetite (Fe 3 O 4 )–Avastin nanocomposite as a potential drug for AMD treatment

  2018cites this paper
• Inhibition of VEGF‐dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a

  2018cites this paper
• Recent Innovations in Drug Delivery for Retinal Diseases

  2018cites this paper
• Assessment of the long-term visual and anatomical outcomes of ranibizumab to treat neovascular age-related macular degeneration.

  2018cites this paper
• Cost-effectiveness of intravitreal aflibercept versus other treatments for wet age-related macular degeneration in Japan

  2017cites this paper
• Utilizing Zebrafish Visual Behaviors in Drug Screening for Retinal Degeneration

  2017cites this paper
• Vitamin D and Age-Related Macular Degeneration

  2017influential citation
• Hydrogel Formulations for Ophthalmic Delivery

  2017cites this paper
• Evaluation of effect of bevacizumab on central subfield macular thickness in the injected and contralateral (untreated) eye of patients with bilateral diabetic macular oedema

  2017cites this paper
• Normotensive Glaucoma Follow-Up with Incidental Finding of Choroidal Neovascular Membrane: a Teaching Case Report.

  2017cites this paper
• Novel risk index for the identification of age-related macular degeneration using radon transform and DWT features

  2016cites this paper
• Optimization of novel pentablock copolymer based composite formulation for sustained delivery of peptide/protein in the treatment of ocular diseases

  2016cites this paper
• Distinct Responsiveness to Intravitreal Ranibizumab Therapy in Polypoidal Choroidal Vasculopathy With Single or Multiple Polyps.

  2016cites this paper
• Clearance of autophagy-associated dying retinal pigment epithelial cells – a possible source for inflammation in age-related macular degeneration

  2016cites this paper
• Quantification of choroidal neovascularization vessel length using optical coherence tomography angiography

  2016cites this paper
• PLGA Depots for Controlled Release of Bevacizumab.

  2016cites this paper
• PIGMENT EPITHELIAL DETACHMENT RESPONSE TO AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO RANIBIZUMAB: Time Course and Drug Effects

  2016cites this paper
• In vitro investigation of the clearance of anoikic and autophagy-associated dying retinal pigment epithelial cells – implications for age-related macular degeneration by Mária Szatmári-Tóth

  2016cites this paper
• Retinal Toxicity of Intravitreal Injection of Ziv-Aflibercept in Albino Rabbits

  2016influential citation
• Aflibercept vs. Ranibizumab: cost‐effectiveness of treatment for wet age‐related macular degeneration in Sweden

  2016cites this paper
• Increased serum IgA concentration and plasmablast frequency in patients with age-related macular degeneration.

  2016cites this paper
• Novel Pentablock Copolymer-Based Nanoparticulate Systems for Sustained Protein Delivery

  2015cites this paper
• A model microfluidics-based system for the human and mouse retina

  2015cites this paper
• Controlling the Progression of Age-related Macular Degeneration Using the Image Quality Index and the Reference Image

  2015cites this paper
• A review of optical coherence tomography angiography (OCTA)

  2015cites this paper
• Tailor-Made Pentablock Copolymer Based Formulation for Sustained Ocular Delivery of Protein Therapeutics

  2014cites this paper
• Novel thermosensitive pentablock copolymers for sustained delivery of proteins in the treatment of posterior segment diseases.

  2014influential citation
• Drug Life Cycle

  2014cites this paper
• Investigation of the role of the TLR3 innate immunity pathway in the pathogenesis of age-related macular degeneration

  2014cites this paper
• Filtros ópticos contra el efecto fototóxico del espectro visible en la retina : experimentación animal

  2014cites this paper
• Visualization of retinal vascular structure and perfusion with a nonconfocal adaptive optics scanning light ophthalmoscope.

  2014cites this paper
• A quantitative approach to identify morphological features relevant for visual function in ranibizumab therapy of neovascular AMD.

  2014cites this paper
• Availability of resources for patients with wet age-related macular degeneration. Optimal study

  2013cites this paper
• [Availability of resources for patients with wet age-related macular degeneration. Optimal study].

  2013cites this paper
• Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles.

  2013cites this paper
• Classification of wet aged related macular degeneration using optical coherence tomographic images

  2013cites this paper
• Erfahrungen mit intravitrealem Bevacizumab (Avastin®) bei exsudativer, altersabhängiger Makuladegeneration

  2013cites this paper
• Analyzing and Forecasting the Fusion Protein Market and Pipeline

  2013cites this paper
• Disponibilidad de recursos para pacientes con degeneración macular asociada a la edad de tipo húmedo. Estudio Optimal

  2013cites this paper
• Evaluation of Tissue Interactions with Mechanical Elements of a Transscleral Drug Delivery Device

  2012cites this paper
• Suppression of Experimental Choroidal Neovascularization by Curcumin in Mice

  2012cites this paper
• Structure-Function Studies of Nicotinic Acetylcholine Receptors Using Unnatural Amino Acids and Synthetic Agonist Analogs

  2012cites this paper
• Ranibizumab

  2012cites this paper
• β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization.

  2012cites this paper
• Evaluation of RPE65, CRALBP, VEGF, CD68, and Tyrosinase Gene Expression in Human Retinal Pigment Epithelial Cells Cultured on Amniotic Membrane

  2011cites this paper
• Calidad de imagen en sujetos afectados de degeneración macular asociada a la edad y queratitis

  2011cites this paper
• The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration.

  2011cites this paper
• New testing software for quantifying discrimination capacity in subjects with ocular pathologies.

  2011cites this paper
• Residual abilities in age-related macular degeneration to process spatial frequencies during natural scene categorization

  2011cites this paper
• Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.

  2011cites this paper
• Neovascular Age-Related Macular Degeneration

  2011cites this paper
• Effects of Photodynamic Therapy in Combination with Anti-Angiogenic Drugs on the Chicken Chorioallantoic Membrane Model

  2011cites this paper
• Enhanced differentiation of retinal progenitor cells using microfabricated topographical cues

  2010cites this paper
• Arzneiformen zur Verabreichung von Proteinen am und im Auge

  2010influential citation
• Retinal-Image Quality and Contrast-Sensitivity Function in Age-Related Macular Degeneration

  2010cites this paper
• Study of complement regulatory factor H based on Forster resonance energy transfer and investigation of disease-linked genetic variants

  2010cites this paper
• Clinical status of duplex RNA.

  2010cites this paper
• Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes

  2010cites this paper
• Consequences and Utility of the Zinc-Dependent Metalloprotease Activity of Anthrax Lethal Toxin

  2010cites this paper
• Development of a novel homogenous electrochemiluminescence assay for quantitation of ranibizumab in human serum.

  2010cites this paper
• Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response

  2009cites this paper
• Nature: a vital source of leads for anticancer drug development

  2009cites this paper
• Recognition of facial emotion in low vision: A flexible usage of facial features

  2008cites this paper
• Answer: Answer to Ophthaproblem.

  2008cites this paper